Reliance’s Strand Life Sciences secures Indian patent for blood-based early cancer detection…
New Delhi : Strand Life Sciences, a subsidiary of Reliance Industries Limited, has been granted an Indian patent for its integrated platform that enables early cancer detection from a simple blood test using cell-free DNA (cfDNA) analysis,…
